Heart failure as a cardiac manifestation of sarcoidosis. Successful treatment of heart failure with steroids, digitalis, and an angiotensin-1 receptor antagonist;Herzinsuffizienz als kardiale manifestation einer sarkoidose. Erfolgreiche therapie der herzinsuffizienz mit steroiden, digitalis und einem angiotensin-1-rezeptor-antagonisten bei sarkoidose

Medizinische Klinik

Volumn 95, Issue 3, 2000, Pages 151-157

  Oldenburg, Olaf ^a,b   Schäfers, Raphael F ^a,b   Kuntz, Stephanie ^b   Sack, Stefan ^a   Erbel, Raimund ^a   Philipp, Thomas ^b   Weber, Franz ^b  

^a Herzzentrum Ludwigshafen   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Boeck's disease; Congestive heart failure; Drug therapy; Myocardial manifestation; Sarcoidosis

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; CAPTOPRIL; DIGITALIS; DIGITOXIN; GLYCOSIDE; LOSARTAN POTASSIUM; PREDNISONE; STEROID;

ADULT; ARTICLE; CASE REPORT; CHILL; DYSPNEA; ELECTROCARDIOGRAM; FEMALE; FEVER; HEART ARRHYTHMIA; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HUMAN TISSUE; SARCOIDOSIS; SYMPTOMATOLOGY; THORAX RADIOGRAPHY;

DIGITALIS;

EID: 0342748614     PISSN: 07235003     EISSN: None     Source Type: Journal    
DOI: 10.1007/pl00002097     Document Type: Article

References (32)

1. Abeler V. Sarcoidosis of the cardiac conduction system. Am Heart J 1979;97:701-7.
2. Adams KF Jr, Gheorghiade M, Uretsky BF, et al. Patients with mild heart failure worsen during withdrawal from digoxin therapy. J Am Coll Cardiol 1997;30:42-8.
3. Bach P, Zähringer J, Steinbeck G, et al. Myokardinfarkt als Erstmanifestation einer Myokardbeteiligung bei asymptomatischem Morbus Boeck. Internist (Berlin) 1987:28:273-7.
4. Badorff C, Schwimmbeck PL, Kühl U, et al. Kardiale Sarkoidose: Diagnosesicherung durch Endokardbiopsie und Therapie mit Kortikosteroiden. Z Kardiol 1997;86:9-14.
5. Bolognia J, Braverman IM.: Skin manifestations of internal diseases. In: Isselbacher KJ, Braunwald E, Wilson JD, et al., eds. Harrison's principles of internal medicine, 13th edn. New York: McGraw-Hill, 1994:292.
6. Chin BB, Civelek AC, Mudun A. Resting Tl-201 scintigraphy in the evaluation of myocardial sarcoidosis. Clin Nucl Med 1997:22:475-8.
7. Claussen M, Kirsten D, Amthor M, et al. Epitheloidzellige Granulomatose mit beidseitigen gröflächigen Lungenverschattungen. Med Klin 1996;91:199-204.
8. Crystal RC. Sarcoidosis. In: Isselbacher KJ, Braunwald E, Wilson JD, et al., eds. Harrison's principles of internal medicine, 13th edn. New York: McGraw-Hill, 1994: 1679-84.
9. Fields CL, Ossorio MA, Roy TM, et al. Thallium-201 scintigraphy in the diagnosis and management of myocardial sarcoidosis. South MedJ 1990;83:339-42.
10. Galinier M, Albenque JP, Afchar N, et al. Prognostic value of late potentials in patients with congestive heart failure. Eur Heart J 1996;17:264-71.
11. Hoppe UC, Erdmann E. Leitlinien zur Therapie der chronischen Herzinsuffizienz. Z Kardiol 1998;87: 645-61.
12. Kimani AP, Aguayo SM. Sarcoidosis: an overview for the primary care physician. Comp Ther 1998;24:20-5.
13. Kroegel C, Buhl R, Müller-Querheim J, et al. Update Pneumologie '95. Fortschritte und Perspektiven in der Pneumologie. Paradigma des Wandels (Teil II). Med Klin 1995;90:343-57.
14. Kurata C, Sakata K, Taguchi T, et al. SPECT imaging with Tl-201 and Ga-67 in myocardial sarcoidosis. Clin Nucl Med 1990;15:408-11.
15. Morales AR, Levy S, Davis J, et al. Sarcoidosis and the heart. Pathol Annu 1974;9:113-8.
16. Müller-Quernheim J, Dalhoff K, Schnabel A. Immunsuppressive Therapie bei interstitiellen Lungenerkrankungen und immulologisch vermittelten Pneumonien. Internist (Berlin) 1997;38:553-61.
17. Pitt B, Segal R, Martinez FA, et al. Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE). Lancet 1997;349:747-52.
18. Ratner SJ, Fenoglio JJ Jr, Ursell PC. Utility of endocardial biopsy in the diagnosis of cardiac sarcoidosis. Chest 1986:90:528-33.
19. Riaz K, Forker AD. Digoxin use in congestive heart failure. Current status. Drugs 1998;55:747-58.
20. Scharkoff, T. Epidemiologie der Sarkoidose. Pneumologie 1993;47:588-92.
21. Scully RE, Mark EJ, McNeely WF, et al. Case records of the Massachusetts General Hospital. Case 44-1990. N Engl J Med 1990;323:1261-70.
22. Sekiguchi M, Hiroe M, Take M, et al. Clinical and histopathological profile of sarcoidosis of the heart and acute idiopathic myocarditis. Concepts through a study employing endomyocardial biopsy. I. Sarcoidosis. Jpn Circ J 1980;44:249-63.
23. Sharma OP, Maheshwari A, Thaker K. Myocardial sarcoidosis. Chest 1993:103:253-8.
24. Shiotani H, Miyazaki T, Matsunaga K, et al. Improvement of severe heart failure with corticosteroid therapy in a patient with myocardial sarcoidosis. Jpn Circ J 1991:55: 393-6.
25. Silverman KJ, Hutchins GM, Bulkley BH. Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation 1978;58:1204-11.
26. So CS. Praktische Elektrokardiographie, 7. Aufl. Stuttgart: Thieme, 1996:25.
27. Soler-Soler J, Permanyer-Miralda G. Should we still prescribe digoxin in mild-to-moderate heart failure? Is quality of life the issue rather than quantity? Eur Heart J 1998; 19:P26-31.
28. Stein E, Jackler I, Stimmel B, et al. Asymptomatic electrocardiographic alterations in sarcoidosis. Am Heart J 1973:86:474-7.
29. Tei C, Dujardin KS, Hodge DO, et al. Doppler index combining systolic and diastolic myocardial performance: clinical value in cardiac amyloidosis. J Am Coll Cardiol 1996;28:658-64.
30. The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 1997;336:525-33.
31. Wait JL, Movahed A. Anginal chest pain in sarcoidosis. Thorax 1989;44:391-5.
32. Winters SL, Cohen M, Greenberg S, et al. Sustained ventricular tachycardia associated with sarcoidosis: Assessment of the underlying cardiac anatomy and the prospective utility of programmed ventricular stimulation, drug therapy and an implantable antitachycardia device. J Am Coll Cardiol 1991;18:937-43.